Prevalence of HCV-HIV coinfection. newborn babies
|
|
- Barbra Spencer
- 5 years ago
- Views:
Transcription
1 Prevalence of HCV-HIV coinfection among mothers of newborn babies Mercedes Díez Secretariat of the National Plan on AIDS National Center of Epidemilogy Madrid, 24 November 26
2 Overview Background HIV epidemic in Spain Transmission patterns Overlap with HCV Unlinked Anonymous Testing (UAT) Methodology Results HIV prevalence Prevalence of HCV-HIV co-infection Conclusions
3 AIDS cases per million population in selected countries, , western Europe 2 Cases per million 15 Update 3 June Year of diagnosis Portugal Spain Italy France United Kingdom Germany EuroHIV
4 New annual AIDS cases by transmission category, adjusted for reporting delay. National AIDS Register. Updated June 3th, IDU Homosexual Heterosexual * 24* 25*
5 AIDS cases diagnosed in 25, by sex and transmission category. National AIDS Register. Updated June 3th, 26 Trans/hem,3% Hetero. 23,9% MTCT,2% Hetero. 53,9% MTCT 1,2% Homosex. 19,8% Otros/desc 5,1% Other 7,8% Men (n = 1134) IDU 5,7% Trans/Hem,3% IDU 36,8% Women (n = 345)
6 New HIV diagnosis by transmission category Data from 7 AARR (21-24) Casos IDU Hetero MSM MTCT Data: Canary Islands, Catalonia,Ceuta, Navarra, Basque Country, Extremadura and La Rioja
7 9 8 No. of AIDS cases due to mother-to-child transmission, adjusted by reporting delay National AIDS Register. Update at June 3th, 26 HAART Inhibidores de la proteasa Cases * 24* 25*
8 Natural History of HCV infection FREE OF DISEASE PRIMOINFECTION 2-5% CLEARANCE 5-8% CRONIC HEPATITIS CIRRHOSIS 2% ACUTE HEPATITIS 8% Asyntomatic HEPATOCELULAR CARCINOMA 1,5% TIME
9 Hospital Discharge Diagnosis among deceased HIV/AIDS patients, Porcentaje sobre el total de fallecidos en cada año ,8 3,4 34,8 4,7 7,5 4,7 68,5 62,1 6,5 41,9 5,8 52, HIV-related AIDS indicative Disease Other χ2 test for trend: p<.5 Source: CMBD ( )
10 Hospitalisations (N, %) due to viral hepatitis among HIV/AIDS patients, N(%) N(%) N(%) N(%) Hepatitis C* (17,6) (21,) (24,6) (26,3) Hepatitis B 771 (3,6) 83 (4,) Other viral hepatitis 814 (4,1) 79 (4,) Hepatitis A 12 (,1) 12 (,1) 4 () 16 (,1) Hepatitis Delta (wth hep B) 14 (,1) 15 (,1) 2 (,1) 16 (,1) Hepatitis E 5 () 4 () 3 () 1 () Other 17 (,1) 14 (,1) 17 (,1) 6 (,1) A patient can have more than one diagnosis *p<.5 en χ2 test for trnd Source: CMBD
11 Hospitalisations (%) due to acute/chronic Hepatitis B or C among HIV/AIDS patients p<.5 Porcentaje p<.5 5 Acute Hep B Chronic Hep B Acute Hep C Chronic Hep C Hepatitis víricas A patient can have more than one diagnosis p: χ2 test for trnd Source: CMBD
12 To sum up... High HIV/AIDS incidence in Spain. Many years, highest in Western Europe Mature concentrated epidemic Intravenous drug users (IDU), most commonly represented transmission category, but epidemic pattern has changed recently IDUs also at high risk for HCV Need to prevent HIV and HCV MTCT Need to establish information systems to know HIV & HIV-HCV prevalence in general population
13 HIV Prev:,3% (3-7% co-infected with HCV) VIH HCV Prev HIV-HCV:?? VIH/VHC HCV Prev: 1,5-2,5% Distribution of HIV & HCV infection in the Spanish population Wordwide Prev HCV: 3% Source: WHO
14 Unlinked Anonimous Testing in newborn babies Epidemiological information system Iinitiated in 1998 Setting: 8 Autonomous Regions Residual dried blood spots samples from routine neonatal screening Unlinked for identifiers Tested anonymously for HIV. All HIVpositive samples tested for Anti- HVC
15 Methodology- Dried blood samples Type 1 Type 2
16 Objetives To estimate prevalence of HIV infection in mothers of newborn babies To estimate prevalence of HIV-HCV coinfection in mothers of newborn babies
17 UAT Results, 24 (7 AR) Blood Samples HIV(+) Anti-HCV in HIV(+) Autonomous Regions No. Tested HIV(+)/1 women (IC95%) Anti- HCV (n) Anti-HCV (%) (IC95%) Proportion HIV-HVC+ /HIV+ CANARY ISLANDS ,15 (1,31-3,32) 4,43(,12-1,1) 2, CASTILLE- LEON ,11 (,7-1,69) 8,41(,17-,8) 36,36 CASTILLE-LA MANCHA 6.981,86 (,32-1,87) GALICE MELILLA MURCIA C. VALENCIANA TOTAL ,7 (1,15-2,42 ),74 (,2-4,1 ),8 (,43-1,37 ) 1,81 (1,45-2,22 ) 1,5 (1,29-1,74) ,62 (,31-1,11),25 (,7-,63),37(,22-,58),38 (,27-,5) 37,93 36,36 21,69 26,47
18 Results. Period (5 AR) HIV HCV-HIV Autonomous Regions Number Tested Prev.HIV +/1 (IC95%) HCV + (n) Prev.HIV-HVC +/1 (IC95%) Proportion HIV-HVC+ /HIV+ CANARY ISLANDS 12, ( ) ( ) CASTILLE- LEON 16, ( ) 5.47 ( ) GALICE 125, ( ) 88.7 ( ) MELILLA 7, ( ) 1.13 (.-.75) MURCIA 11, ( ) ( ) TOTAL 444, ( ) ( ) 39.5 HIV + ( ): 618 HCV tested HVC: 562 (9,9%)
19 HIV(+) mothers. Proportion with Anti-HCV , 5 AARR Percentage , Year HIV + ( ): 618 HCV tested HVC: 562 (9,9%)
20 HIV(+) mothers. Proportion with Anti-HCV by Autonomous Regions Percentage Canary Islands Castille-Leon Galice Murcia Melilla HIV + ( ): 618 Tested HVC: 562 (9,9%)
21 Prevalence of de HIV and HIV-HCV co-infection per 1 women (5 AARR) 2 Prevalence/1 women 1,6 1,2,8, Year HIV/1. HIV-HCV/1. Chi- Square of tendency: NS
22 Prevalence of HIV and HIV-HCV co-infection per 1 women. Canary Islands 6 p<.5 2,5 Percentage ,5 1,5 Prevalence/1 women % COINFECTION HIV/1. HIV-HCV/1. Chi- Square of tendency prevalence HIV/HCV: NS
23 Prevalence of HIV and HIV-HCV co-infection per 1 women. Castille-Leon ,5 Percentage ,5 1,5 Prevalence/1 women % COINFECTION HIV/1. HIV-HCV/1. Chi- Square of tendency prevalence HIV/HCV and prevalence HIV: NS
24 Prevalence of HIV and HIV-HCV co-infection per 1 women. Galice 7 2,5 Percentage ,5 1,5 Prevalence/1 women % COINFECTION HIV/1. HIV-HCV/1. Chi- Square of tendency prevalence HIV/HCV and prevalence HIV: NS
25 Prevalence of HIV and HIV-HCV co-infection per 1 women. Murcia 6 1,8 Percentage ,6 1,4 1,2 1,8,6,4,2 Prevalence/1 women % COINFECTION HIV/1. HIV-HCV/1. Chi- Square of tendency prevalence HIV/HCV and prevalence HIV: NS
26 Conclusions UAT using residual dried blood spots samples from routine neonatal screening is feasible and costeffective It provides important information on HIV infection and HCV-HIV co-infection trends, in unselected group of the Spanish population Prevalence of HIV-ACV is high in comparison with other European countries, and stable during HCV testing should always be done in HIV(+) pregnant women, as well as in all those with risk factors for HCV infection Challenges: a) extend the program to other AARR; b) add some important epidemiological variables
ANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
SECRETARÍA GENERAL DE SANIDAD DIRECCIÓN GENERAL DE SALUD PÚBLICA Y SANIDAD EXTERIOR ANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
More informationViral Hepatitis Burden and Policy Directions in the European Region of WHO
Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all
More informationSupervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles
I Congreso de GESIDA Madrid, 21-24 de Octubre del 2009. Supervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles José M. Miró, 1 Miguel Montejo,
More informationStrategies to Address HCV
Strategies to Address HCV HIV Programs & U.S. Viral Hepatitis Action Plan Corinna Dan, RN, M.P.H. Viral Hepatitis Policy Advisor Office of HIV/AIDS and Infectious Disease Policy September 10, 2015 1 The
More informationEDMA HIV-AIDS TEAM Fact Sheet November 2007
EDMA HIV-AIDS TEAM Fact Sheet November 2007 1. HIV Facts AIDS epidemic update UNAIDS Epidemic Update, November 2007 (1) 760,000 people to be living with HIV in Western and Central Europe in 2007. 31,000
More informationPlanning and health programmes
Planning and Health plans are the principal instrument used by the authorities to guide and direct their resources towards previously defined objectives of. They embrace the main objectives of the corresponding
More informationThe current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint
The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution
More informationSTRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA
STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA Simona Claudia CAMBREA MD, Ph D Faculty of Medicine, Ovidius University, Constanta, Romania Clinical Infectious
More informationECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
More informationHarm reduction among drug users in Spain
Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández
More informationHIV/AIDS in China. -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA
HIV/AIDS in China -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA September 12, 2008 1 HIV epidemic in Asia General Population
More informationHIV, HBV and HCV testing policy experiences and lessons learned.
HIV, HBV and HCV testing policy experiences and lessons learned. Contents HIV and viral hepatitis: distinct epidemics at different stages of evolution Epidemiology: transmission, prevalence, incidence
More informationCivil Society Driven Response in Ukraine: A program making a difference and bringing results
Civil Society Driven Response in Ukraine: A program making a difference and bringing results CATIE Forum Making it work: From Planning to Practice October 16th, 2015 Andriy Klepikov International HIV/AIDS
More informationConsumer Price Index (CPI). Base 2006 October Monthly change Change over last December
12 November 2010 Consumer Price Index (CPI). Base 2006 October 2010 Overall index Monthly change Change over last Annual change October 0.9 1.8 2.3 Main results The annual change of the CPI for the of
More informationImproving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros
Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal Henrique Barros Ministério da Saúde HIV Testing Knowledge of HIV serostatus has been increasingly
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationECDC s role in the fight against HIV/AIDS in Europe
European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November
More informationHIV EPIDEMIC UPDATE: FACTS & FIGURES 2012
HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a
More informationHIV/Hepatitis co-infection situation in Romania. Oana Săndulescu, MD, PhD
HIV/Hepatitis co-infection situation in Oana Săndulescu, MD, PhD Carol Davila University of Medicine and Pharmacy National Institute of Infectious Diseases Prof. Dr. Matei Balș Bucharest, Disclosures Carol
More informationUpdate on HCV and other infections related to injection drug use. Ann Thomas, MD, MPH Acute and Communicable Disease Prevention
Update on HCV and other infections related to injection drug use Ann Thomas, MD, MPH Acute and Communicable Disease Prevention Dec 14, 2018 Overview Update on NHANES prevalence data Trends in HCV, HIV
More informationUpdate on HIV-HCV Epidemiology and Natural History
Update on HIV-HCV Epidemiology and Natural History Jennifer Price, MD Assistant Clinical Professor of Medicine University of California, San Francisco Learning Objectives Upon completion of this presentation,
More informationProject SUCCEED Overview. Project Scaling-Up Co-Infection Care to End Ethnic Disparities Brooklyn Hep C Task Force February 6, 2018
Project SUCCEED Overview Project Scaling-Up Co-Infection Care to End Ethnic Disparities Brooklyn Hep C Task Force February 6, 2018 2 Goals and Objectives Goal: to eliminate hepatitis C (HCV) amongst people
More informationChallenges for viral hepatitis prevention in Latin American
Challenges for viral hepatitis prevention in Latin American One in three people on earth has been exposed to hepatitis B or C viruses (HBV and HCV); HBV and HCV are responsible for 57% of cirrhosis and
More informationMetro St. Louis HIV Epidemiological Profile
Metro St. Louis HIV Epidemiological Profile Saint Louis TGA Part A Planning Council Prepared by the City of St. Louis Department of Health s Center for Health Information, Research, and Planning Table
More informationScreening programmes for Hepatitis B/C in Europe
Programme STI, HIV/AIDS and viral hepatitis Screening programmes for Hepatitis B/C in Europe Mika Salminen, Ph.D. European Centre for Disease Prevention and Control Why might screening be needed for hepatitis
More informationCurrent Hepatitis B and C Screening Practices for Migrants and Barriers to Screening
Current Hepatitis B and C Screening Practices for Migrants and Barriers to Screening Amena Ahmad, Ralf Reintjes Hamburg University of Applied Sciences, Germany European Conference on Migrant and Ethnic
More informationHispanics/Latinos and Hepatitis: An Overlooked Health Disparity. National Hispanic Hepatitis Awareness Day
Hispanics/Latinos and Hepatitis: An Overlooked Health Disparity National Hispanic Hepatitis Awareness Day HELLO! LUIS A. MARES, LMSW Director of Community Mobilization Latino Commission on AIDS. Lmares@latinoaids.org
More informationHepatitis C reinfection after sustained virological response in HIV/HCV co-infected patients
Hepatitis C reinfection after sustained virological response in HIV/HCV co-infected patients Fábio Videira Santos, Joana Fragoso, Ana Cipriano, Miguel Araújo Abreu, Olga Vasconcelos, Ana Aboim Horta, Ana
More informationHepatitis situation in the Republic of Macedonia
Hepatitis situation in the Republic of Macedonia Presented by Viktorija Chaloska Ivanova University Clinic of Gastroenterology Skopje, Republic of Macedonia Hepatitis Prevalence/incidence in Macedonia
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationHIV and Paediatrics in Central Europe
2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV HIV and Paediatrics in Central Europe Mariana Mărdărescu MD PhD Consultant in Infectious Diseases Senior Doctor in
More informationHBV/HCV COINFECTIONS IN PATIENTS WITH HIV. Dr Reena Harania MBBS, MRCP, MSc Infectious Disease
HBV/HCV COINFECTIONS IN PATIENTS WITH HIV Dr Reena Harania MBBS, MRCP, MSc Infectious Disease Adults and children estimated to be living with HIV as of end 2005 North America 1.2 million [650 000 1.8 million]
More informationViral Hepatitis. WHO Regional Office for Europe July 2013
Viral Hepatitis WHO Regional Office for Europe July 2013 What is Hepatitis? Hepatitis is a viral infection that causes inflammation of the liver There are five main types of viral hepatitis: A, B, C, D,
More informationTetiana Kyrychenko MD. Poltava Regional HIV/AIDS Prevention and Control Center. 4TH CEE MEETING ON VIRAL HEPATITIS AND HIV October 2018, Prague
Tetiana Kyrychenko MD Poltava Regional HIV/AIDS Prevention and Control Center 4TH CEE MEETING ON VIRAL HEPATITIS AND HIV 11-12 October 2018, Prague tanakyrychenko@gmail.com Disclosures No relevant conflicts
More informationKey issues for HIV testing and
Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics
More informationDTD 1. Hepatitis C and HIV. Douglas T. Dieterich, MD Associate Professor of Medicine NYU School of Medicine
DTD 1 Hepatitis C and HIV Douglas T. Dieterich, MD Associate Professor of Medicine NYU School of Medicine DTD 2 Issues Similarities between HIV and HCV Incidence/prevalence of co-infection Overlapping
More information28.8% of deaths were due to diseases of the circulatory system and 26.7% to tumours
19 December 2018 Deaths according to cause of death Year 2017 28.8% of deaths were due to diseases of the circulatory system and 26.7% to tumours Diseases of the respiratory system increased by 10.3% and
More informationProject SUCCEED Scaling up Co Infection Care & Eliminating Ethnic Disparities 13 th Annual Iris House Women As the Face of AIDS Summit May 7th, 2018
Project SUCCEED Scaling up Co Infection Care & Eliminating Ethnic Disparities 13 th Annual Iris House Women As the Face of AIDS Summit May 7th, 2018 2 Project SUCCEED Team Natalie Octave, MPH, CHES Project
More information10/07/18. Dr. Otilia Mårdh, ECDC. No conflicts of interest.
No conflicts of interest. Prevention and control of chlamydia in Europe from data to policies and testing recommendations Dr. Otilia Mårdh, ECDC 15th Congress of the European Society of Contraception and
More informationUNGASS COUNTRY PROGRESS REPORT SINGAPORE
UNGASS COUNTRY PROGRESS REPORT SINGAPORE Submission date: 14 March 2008 Reporting period: January 2006 December 2007 I. Overview of the HIV/AIDS epidemic Singapore is categorized as a low-prevalence epidemic.
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationHIV in the United Kingdom: 2009 Report
HIV in the United Kingdom: 2009 Report Key findings The number of people living with HIV in the UK continues to rise, with an estimated 83,000 infected at the end of 2008, of whom over a quarter (27%)
More informationThe evolution of HIV/AIDS Epidemic in Romania 31 December 2013
The evolution of HIV/AIDS Epidemic in Romania 31 December 2013 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS Data
More informationECDC update to the EU Commission Think Tank on HIV/AIDS
ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think
More informationSTRATEGIC PLAN FOR TACKLING HEPATITIS C IN THE SPANISH NATIONAL HEALTH SYSTEM
MINISTRY OF HEALTH, SOCIAL SERVICES AND EQUALITY OFFICE OF THE SECRETARY FOR HEALTH AND CONSUMER AFFAIRS STRATEGIC PLAN FOR TACKLING HEPATITIS C IN THE SPANISH NATIONAL HEALTH SYSTEM May 21, 2015 SCIENTIFIC
More informationProfessor Norbert Bräu
Sixth Annual BHIVA Conference for the Management of HIV/Hepatitis Co-Infection in collaboration with BASL and BVHG Professor Norbert Bräu James J Peters VA Medical Center, New York, USA COMPETING INTEREST
More informationHIV epidemic around the Baltic Sea
HIV epidemic around the Baltic Sea Pauli Leinikki National Public Health Institute Subtitles Statistics: what seems to have happened Dynamics: in what order Dissection: what actually happened Target friendly
More informationAs a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
More informationHIV/AIDS in East Asia
HIV/AIDS in East Asia Yonsei University Graduate School of Global Health Sohn, Myong Sei Epidemiology Global summary of the AIDS epidemic, 2008 Number of people living with HIV in 2008 Total Adults Women
More informationELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD
ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD 17 May 2018 Bucharest, Romania Organisers Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe
More informationJust Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health
Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health March 12, 2018 Envisioning a socially just system where all New Yorkers
More informationPublic Health Response to HCV in Oregon: Need for Screening and Treatment. Ann Thomas, MD, MPH Acute and Communicable Disease Prevention
Public Health Response to HCV in Oregon: Need for Screening and Treatment Ann Thomas, MD, MPH Acute and Communicable Disease Prevention November 29, 2018 Outline I. Epidemiology of HCV in OR acute HCV,
More informationHIV in Prison Situation in Frankfurt am Main
HIV in Prison Situation in Frankfurt am Main European Project ROME-SEMINAR, May 14.-15., 2008 Horst Herkommer, Sella Oneko Praxis Psychosoziale Beratung Frankfurt am Main Germany General remark: Situation
More informationLiver stiffness predicts liver related events and mortality in HIV/HCV coinfected patients
Liver stiffness predicts liver related events and mortality in HIV/HCV coinfected patients José Vicente Fernández-Montero, Pablo Barreiro, Eugenia Vispo, Pablo Labarga, Francisco Blanco, Fernanda Rick,
More informationWho is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers
HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National
More informationTreatment of Hepatitis C in HIV-Coinfected Patients. Vincent Soriano Department of Infectious Diseases Hospital Carlos III Madrid, Spain
Treatment of Hepatitis C in HIV-Coinfected Patients Vincent Soriano Department of Infectious Diseases Hospital Carlos III Madrid, Spain Estimated no. of persons infected with HIV and hepatitis viruses
More informationLinkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians
Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians Shana Geary, MPH, CPH United States Conference on AIDS September 7,
More informationHIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy
HIV in Russia Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy Elisa F. Long, M.S. Margaret L. Brandeau, Ph.D. Tatyana Vinichenko, M.D., M.P.A. Cristina M. Galvin, M.S. Swati
More informationINTRAVENOUS INJECTING DRUG USE.
Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been
More informationEAST LONDON INTEGRATED CARE
CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver
More informationNumbers HCV and HIV Epidemiology in the US
By The Numbers HCV and HIV Epidemiology in the US Coinfection Fridays Session 1 18 January 2019 Christopher B. Hurt, MD Associate Professor of Medicine Co-Director, North Carolina AIDS Training & Education
More informationHIV-HBV coinfection in HIV population horizontally infected in early childhood between
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE HIV-HBV coinfection in HIV population horizontally infected in early childhood between 1987-1990 Supervising professor: Prof. Cupşa Augustin
More informationTreatment of chronic hepatitis C in HIV co-infected patients
Treatment of chronic hepatitis C in HIV co-infected patients Vicente Soriano Department of Infectious Diseases Hospital Carlos III, Madrid, Spain The most prevalent chronic viral infections in humans HBV
More informationConsumer Price Index (CPI). Base 2011 May Monthly change Change over last May Annual change May
12 June 2013 Consumer Price Index (CPI). Base 2011 May 2013 all index Monthly change Change over last May Annual change May 0.2 0.2 1.7 Main results The annual change of the CPI for the month of May stands
More informationOutline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide
Outline AIDS & HIV in the Joshua Vest Epidemiologist Austin/ Health & Human Services Department Worldwide HIV/AIDS surveillance National Prevalence Trends Disparities Mortality Modes of exposure Risk factors
More informationNote: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.
Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting
More informationThe Geography of Viral Hepatitis C in Texas,
The Geography of Viral Hepatitis C in Texas, 1992 1999 Author: Mara Hedrich Faculty Mentor: Joseph Oppong, Department of Geography, College of Arts and Sciences & School of Public Health, UNT Health Sciences
More informationTrends in HIV Incidence and Prevalence in the United States
Trends in HIV Incidence and Prevalence in the United States Irene Hall, PhD, FACE 7th International Workshop on HIV Transmission Washington, DC, July 20, 2012 National Center for HIV/AIDS, Viral Hepatitis,
More informationELPA S VISION OF SCREENING
ELPA S VISION OF SCREENING By Nadine Piorkowsky President of the European Liver Patients Association, Budapest, 18-19 March 2010 ELPA s network The Patient s View a viral time bomb: Up to 9 out of 10 chronic
More informationPrevention and control of hepatitis B and C in the European Region of WHO
Prevention and control of hepatitis B and C in the European Region of WHO Viral Hepatitis Prevention Board Dr Nedret Emiroglu WHO Regional Office for Europe Burden of viral hepatitis in the European Region
More informationHepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences
Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious
More informationInfluence of Baseline HCV Genotype upon Treatment Outcome of Acute HCV Infection in HIV Co-Infected Individuals
Influence of Baseline HCV Genotype upon Treatment Outcome of Acute HCV Infection in HIV Co-Infected Individuals Christoph Boesecke, Hans-Jürgen Stellbrink, Stefan Mauss, Emma Page, Mark Nelson, Sanjay
More informationWorkbook Method for estimating HIV prevalence in low level or concentrated epidemics
Regional Training on Strategic and Operational Planning in HIV & AIDS S P Workbook Method for estimating HIV prevalence in low level or concentrated epidemics Steven Forsythe, PhD Futures Institute/INSP
More informationS P. Strategic Planning and Priority Setting. Barry Kistnasamy Nelson Mandela School of Medicine University of KwaZulu-Natal
ASAP Regional Training on Strategic and Operational Planning in HIV & AIDS S P Strategic Planning and Priority Setting Barry Kistnasamy Nelson Mandela School of Medicine University of KwaZulu-Natal Learning
More informationModule 1: HIV epidemiology, transmission and prevention
Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches
More informationGLOBAL HIV STATISTICS
F A C T S H E E T W O R L D A I D S D A Y 2017 GLOBAL HIV STATISTICS 20.9 million people were accessing antiretroviral therapy in June 2017. 36.7 million [30.8 million 42.9 million] people globally were
More informationMissouri St. Louis TGA 2016 HIV Epidemiological Profile
Missouri St. Louis TGA 2016 HIV Epidemiological Profile St. Louis TGA Part A Planning Council Prepared by the City of St. Louis Department of Health Center for Health Information, Research, and Planning
More informationHepatitis C. Core slides
Hepatitis C Core slides This material was prepared by the Viral Hepatitis Prevention Board The slides (or subsets) can be reproduced for educational use only, with reference to the original source and
More informationHIV/AIDS Joint Action HA-REACT
HIV/AIDS Joint Action HA-REACT Matthias Schuppe Policy Officer Health Threats Unit DG Health and Food Safety European Commission Policy Framework on HIV/AIDS in EU and neighbouring countries Commission
More informationHIV coinfection and HCC
HIV coinfection and HCC 3 rd APASL STC on HCC 21 st -23 rd Nov 2013 Cebu, Phillippines George KK Lau MBBS (HK), MRCP(UK), FHKCP, FHKAM (GI), MD(HK), FRCP (Edin, Lond) Consultant, Humanity and Health GI
More informationSTRATEGIC PLAN AGAINST VIRAL HEPATITIS IN SENEGAL ( ) POLICY BRIEF
PROGRAMME NATIONAL DE LUTTE CONTRE LES HEPATITES STRATEGIC PLAN AGAINST VIRAL HEPATITIS IN SENEGAL (2019-2023) POLICY BRIEF 1 INVESTING IN THE FIGHT AGAINST HEPATITIS B AND C IN SENEGAL NATIONAL STRATEGIC
More informationWelcome to Your Reading Assignment
Welcome to Your Reading Assignment This workbook contains four reading assignments. It is filled with easy-to-read articles you can use to help keep yourself and those you care about safe. After each reading
More informationPrEP for HIV prevention. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint
PrEP for HIV prevention Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution I have
More informationAcute hepatitis C The European Experience
Acute hepatitis C The European Experience Dr Emma Page MBBS MRCP MD(Res) Chelsea and Westminster Hospital, London AHC the European Experience 1. Epidemic 2. CNS sequelae 3. Incidence 4. Re-infection Reports
More informationMortality from viral hepatitis in the Netherlands. S.W. Schalm & M.Toy. Dpts Gastroenterology Hepatology and Public Health Erasmus MC, Rotterdam, NL
Mortality from viral hepatitis in the Netherlands S.W. Schalm & M.Toy Dpts Gastroenterology Hepatology and Public Health Erasmus MC, Rotterdam, NL Burden of disease: chronic viral hepatitis in NL annual
More informationViral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital
Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route
More informationScottish Infected Blood Support Scheme. Payments for People Infected With Hepatitis C or HIV or both from Infected Blood
Scottish Infected Blood Support Scheme Payments for People Infected With Hepatitis C or HIV or both from Infected Blood Introduction The Scottish Infected Blood Support Scheme (SIBSS) is managed by NHS
More informationFormative Research results
FRR Annex 5: Presentation of the FR results in the project meeting, Berlin, 11. 13.02.2013 Formative Research results Sandra Dudareva Vizule, Ulrich Marcus Robert Koch Institute 11 February 2013 Content
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationHepatitis B and C Basics
Hepatitis B and C Basics What is the liver? The liver is the largest internal organ that performs many important functions. Stores nutrients and vitamins Fights infection Stores energy Removes harmful
More informationHPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011
HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011 Health Protection Surveillance Centre, www.hpsc.ie Version 2.1 October, 2012 Table of Contents Acknowledgements... 3 Key Points... 3 Introduction...
More informationThe evolution of HIV/AIDS infection in Romania 31 December 2017
The evolution of HIV/AIDS infection in Romania 31 December 2017 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS
More informationHepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E.
What is Hepatitis? Hepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E. Hepatitis A and E are not chronic and are mostly present in areas
More informationUses and Misuses of Viral Hepatitis Testing. Origins of Liver Science
Uses and Misuses of Viral Hepatitis Testing Richard S Lang, MD, MPH, FACP Chairman, Preventive Medicine Vice-Chair, Wellness Institute Raul J Seballos, MD, FACP Vice-Chair, Preventive Medicine Wellness
More informationHepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006
DOI 10.1007/s10995-015-1853-4 Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006 L. Ghazaryan 1 L. Smith 2 M. Parker 3 C. Flanigan 4 W. Pulver 2 T. Sullivan 5 A.
More informationWESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
More informationPoland nationalupdate
Poland nationalupdate 16th October 2014 Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) Estimation of HIV and HCV prevalence among injecting drug users in
More informationAs a result of this training, participants will be able to:
Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.
More informationSIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item April Viral hepatitis. Report by the Secretariat
SIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item 12.17 16 April 2009 Viral hepatitis Report by the Secretariat THE DISEASES AND BURDEN 1. The group of viruses that cause acute and/or chronic
More information